What Works Skin — Independent · Evidence-First · Ad-FreeIssue 014 · 20 April 2026 · Next: 04 Maywhatworksskin.com

Supplement · Trend Watch · Oral exosomes

P. 22 · BRIEF

Oral exosomes.

Drinking peptide soup. Skip.

The category is built on conflating two genuinely different things: clinical exosome therapeutics under investigation in stem-cell research, and the bottled 'exosome beverages' on luxury wellness shelves. The borrowed credibility is the entire product. We do not recommend it.

— § 02

What the literature shows.

Skin endpoints in oral form

No defensible peer-reviewed RCTs on oral exosomes for skin in humans. The clinical exosome literature is overwhelmingly injectable / topical, not oral.

10%
Bioavailability of oral exosomes
Mechanistic concerns

Exosomes are vesicular structures unlikely to survive gastric digestion intact. The mechanism by which they would deliver a skin endpoint orally is not established.

5%
Topical / clinic exosome therapeutics
Promising small trials

An entirely different category — and not what you are buying when you buy a beverage.

55%
Marketing 'cellular renewal' claims

Aspirational language with no defensible mechanism in the oral form.

5%

— § 03

Forms and bioavailability.

Plant-derived 'exosome' beverage

Absorption · Unestablished

The dominant retail format. Premium pricing per bottle. Marketing-led category.

Stem-cell-derived 'exosome' liquid

Absorption · Unestablished

Sometimes confused with the legitimate clinical exosome therapeutics under research.

Topical exosome serum (clinic)

Absorption · Different category

An entirely separate product class — promising in some peri-procedure protocols. Not the same thing.

Bottom line

A category we cannot justify. The marketing borrows the credibility of legitimate research that does not generalise to the product on the shelf. Save the money.

— § 04

Frequently asked.

Aren't exosomes a real thing in research?

Yes — exosomes are a genuine, important area of biomedical research, primarily in stem-cell therapeutics, regenerative medicine, and as drug-delivery vehicles. None of that research has validated drinking them from a bottle for a skin outcome. The marketing is borrowing the credibility of the research without inheriting the data.

What about the topical exosome serums I see at clinics?

Different category, with more interesting (if still early) data — particularly as adjuncts in post-procedure recovery and microneedling protocols. The topical and the oral story should not be conflated; they are not the same product.

Is it harmful?

Almost certainly not, in the doses sold. The product is largely water, plant extract, and marketing. The harm is to the wallet rather than the body.

What should I spend that money on instead?

A high-quality SPF, a tube of tretinoin, and either oral tranexamic if appropriate or an iron / vitamin D blood test. Any of these will produce more skin endpoint per rupee than any oral exosome product on shelf.